Works matching IS 13419625 AND DT 2025 AND VI 30 AND IP 4

Results: 19
    1
    2
    3
    4

    A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel therapy.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 738, doi. 10.1007/s10147-025-02717-1
    By:
    • Hino, Kaori;
    • Nishina, Tomohiro;
    • Koizumi, Mitsuhito;
    • Marui, Kaori;
    • Kokubu, Masahito;
    • Numata, Yuki;
    • Imamura, Yoshiki;
    • Kanemitsu-Okada, Kozue;
    • Otsuru, Toru;
    • Kuroda, Taira;
    • Ohno, Yoshinori;
    • Asagi, Akinori;
    • Miyata, Hideki;
    • Yokota, Tomoyuki;
    • Kumagi, Teru;
    • Hyodo, Ichinosuke;
    • Ikeda, Yoshio;
    • Hiasa, Yoichi
    Publication type:
    Article
    5

    Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 674, doi. 10.1007/s10147-025-02716-2
    By:
    • Yokoe, Takamichi;
    • Yoshinami, Tetsuhiro;
    • Nozawa, Kazuki;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro
    Publication type:
    Article
    6

    Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatment.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 781, doi. 10.1007/s10147-025-02715-3
    By:
    • Ohba, Kojiro;
    • Osawa, Takahiro;
    • Kojima, Takahiro;
    • Hara, Tomohiko;
    • Sugimoto, Mikio;
    • Eto, Masatoshi;
    • Minami, Keita;
    • Nakai, Yasutomo;
    • Ueda, Kosuke;
    • Naito, Sei;
    • Nonomura, Norio;
    • Murai, Sachiyo;
    • Nishiyama, Hiroyuki;
    • Nakanishi, Hiromi;
    • Mukae, Yuta;
    • Mitsunari, Kensuke;
    • Matsuo, Tomohiro;
    • Imamura, Ryoichi;
    • Shinohara, Nobuo
    Publication type:
    Article
    7
    8
    9
    10

    Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 761, doi. 10.1007/s10147-025-02709-1
    By:
    • Uchimoto, Taizo;
    • Iwatsuki, Kengo;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Saruta, Masanobu;
    • Hashimoto, Mamoru;
    • Minami, Takafumi;
    • Yamamoto, Yutaka;
    • Yamazaki, Shogo;
    • Takai, Tomoaki;
    • Sakamoto, Moritoshi;
    • Nakajima, Yuki;
    • Nishimura, Kazuki;
    • Maenosono, Ryoichi;
    • Tsujino, Takuya;
    • Nakamura, Ko
    Publication type:
    Article
    11

    Prospective observational study on the relationships between genetic alterations and survival in Japanese patients with metastatic castration-sensitive prostate cancer: the impact of IDC-P.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 789, doi. 10.1007/s10147-025-02707-3
    By:
    • Kato, Masashi;
    • Sato, Hiroyuki;
    • Naito, Yushi;
    • Yamamoto, Akiyuki;
    • Kawanishi, Hideji;
    • Nakano, Yojiro;
    • Nishikimi, Toshinori;
    • Kobayashi, Masataka;
    • Kondo, Atsuya;
    • Hirabayashi, Hiroki;
    • Katsuno, Satoshi;
    • Sakamoto, Fumitoshi;
    • Kimura, Tohru;
    • Yamamoto, Shigeki;
    • Araki, Hidemori;
    • Tochigi, Kosuke;
    • Ito, Fumihiro;
    • Hatsuse, Hatsuro;
    • Sassa, Naoto;
    • Hirakawa, Akihiro
    Publication type:
    Article
    12
    13
    14

    Impact of HPV status on oropharyngeal cancer detection via gastrointestinal endoscopy: a retrospective study.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 696, doi. 10.1007/s10147-025-02692-7
    By:
    • Tayama, Sayoko;
    • Miyamoto, Hideaki;
    • Waki, Kotaro;
    • Honda, Munenori;
    • Matsuno, Kenshi;
    • Yamasaki, Akira;
    • Gushima, Ryosuke;
    • Nagaoka, Katsuya;
    • Naoe, Hideaki;
    • Imuta, Masanori;
    • Kawakami, Fumi;
    • Komohara, Yoshihiro;
    • Miyamaru, Satoru;
    • Murakami, Daizo;
    • Orita, Yorihisa;
    • Tanaka, Yasuhito
    Publication type:
    Article
    15
    16

    Survey of healthcare professionals' awareness of appearance care for Japanese cancer patients and their institutions' appearance care systems: report from the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 655, doi. 10.1007/s10147-024-02685-y
    By:
    • Kuji, Shiho;
    • Nozawa, Keiko;
    • Toma, Shoko;
    • Arao, Harue;
    • Imoto, Shigeru;
    • Kajiyama, Hiroaki;
    • Kitano, Atsuko;
    • Kodera, Yasuhiro;
    • Saito, Ryuta;
    • Sakai, Rika;
    • Taketomi, Akinobu;
    • Nakayama, Robert;
    • Hiyama, Eiso;
    • Futamura, Manabu;
    • Matsui, Motohiro;
    • Yonemura, Masahito;
    • Oya, Mototsugu;
    • Suzuki, Nao
    Publication type:
    Article
    17

    Japan society of clinical oncology position paper on appropriate clinical use of molecular residual disease (MRD) testing.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 605, doi. 10.1007/s10147-024-02683-0
    By:
    • Kobayashi, Shin;
    • Nakamura, Yoshiaki;
    • Hashimoto, Tadayoshi;
    • Bando, Hideaki;
    • Oki, Eiji;
    • Karasaki, Takahiro;
    • Horinouchi, Hidehito;
    • Ozaki, Yukinori;
    • Iwata, Hiroji;
    • Kato, Taigo;
    • Miyake, Hideaki;
    • Ohba, Akihiro;
    • Ikeda, Masafumi;
    • Chiyoda, Tatsuyuki;
    • Hasegawa, Kosei;
    • Fujisawa, Takao;
    • Matsuura, Kazuto;
    • Namikawa, Kenjiro;
    • Yajima, Shugo;
    • Yoshino, Takayuki
    Publication type:
    Article
    18
    19

    Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 749, doi. 10.1007/s10147-024-02655-4
    By:
    • Furukawa, Junya;
    • Kato, Taigo;
    • Yamasaki, Toshinari;
    • Monji, Keisuke;
    • Tanaka, Toshiaki;
    • Tsuchiya, Norihiko;
    • Miyagawa, Tomoaki;
    • Yaegashi, Hiroshi;
    • Sano, Tomoyasu;
    • Karashima, Takashi;
    • Fujita, Kazutoshi;
    • Hori, Jun-ichi;
    • Ito, Takayuki;
    • Kajita, Masahiro;
    • Tomita, Yoshihiko;
    • Shinohara, Nobuo;
    • Eto, Masatoshi;
    • Oya, Mototsugu;
    • Uemura, Hirotsugu
    Publication type:
    Article